{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChangePercent": 2.352946, "regularMarketPrice": 0.261, "exchange": "FRA", "shortName": "HAMLET PHARMA AB B O.N.", "longName": "Hamlet Pharma AB (publ)", "messageBoardId": "finmb_13525845", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketTime": 1683875702, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.02, "sharesOutstanding": 72032896, "bookValue": 0.173, "fiftyDayAverage": 0.2876, "fiftyDayAverageChange": -0.026600003, "fiftyDayAverageChangePercent": -0.09248958, "twoHundredDayAverage": 0.30672, "twoHundredDayAverageChange": -0.04571998, "twoHundredDayAverageChangePercent": -0.14906098, "marketCap": 33458634, "priceToBook": 1.5086706, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1620194400000, "priceHint": 4, "regularMarketChange": 0.006000012, "regularMarketDayHigh": 0.261, "regularMarketDayRange": "0.261 - 0.261", "regularMarketDayLow": 0.261, "regularMarketVolume": 13000, "regularMarketPreviousClose": 0.255, "bid": 0.264, "ask": 0.3, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.261, "averageDailyVolume3Month": 220, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.02700001, "fiftyTwoWeekLowChangePercent": 0.11538466, "fiftyTwoWeekRange": "0.234 - 0.385", "fiftyTwoWeekHighChange": -0.12399998, "fiftyTwoWeekHighChangePercent": -0.3220779, "fiftyTwoWeekLow": 0.234, "fiftyTwoWeekHigh": 0.385, "symbol": "7ZT.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "BMC D10", "address2": "Klinikgatan 32", "city": "Lund", "zip": "222 42", "country": "Sweden", "phone": "46 40 12 25 00", "website": "https://www.hamletpharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Hamlet Pharma AB (publ), a pharmaceutical company, engages in the development of drugs for the treatment and prevention of cancer. It is developing HAMLET, a tumoricidal protein-lipid complex formed by two generally regarded as safe (GRAS) molecules found in human milk for various oncology markets, including colon, bladder, and cervix cancers, as well as primary or metastatic brain tumors. The company was incorporated in 1999 and is based in Lund, Sweden. Hamlet Pharma AB (publ) is a subsidiary of Linnane Pharma AB.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Catharina  Svanborg M.D.", "age": 73, "title": "Founder & Chairman", "yearBorn": 1949, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Martin  Erixon", "title": "Chief Exec. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mats  Persson", "age": 61, "title": "Exec. Officer", "yearBorn": 1961, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}